Terms: = Germ cell tumor AND ZFHX3, ATBT, 463, ENSG00000140836, Q15911
109 results:
1. Clinical activity and safety of sintilimab, bevacizumab, and TMZ in patients with recurrent glioblastoma.
Lu Y; Liao L; Du K; Mo J; Zou X; Liang J; Chen J; Tang W; Su L; Wu J; Zhang J; Tan Y
BMC Cancer; 2024 Jan; 24(1):133. PubMed ID: 38273249
[TBL] [Abstract] [Full Text] [Related]
2. Dissecting cellular states of infiltrating microenvironment cells in melanoma by integrating single-cell and bulk transcriptome analysis.
Shi A; Yan M; Pang B; Pang L; Wang Y; Lan Y; Zhang X; Xu J; Ping Y; Hu J
BMC Immunol; 2023 Dec; 24(1):52. PubMed ID: 38082384
[TBL] [Abstract] [Full Text] [Related]
3. Deep convolutional neural network with fusion strategy for skin cancer recognition: model development and validation.
Juan CK; Su YH; Wu CY; Yang CS; Hsu CH; Hung CL; Chen YJ
Sci Rep; 2023 Oct; 13(1):17087. PubMed ID: 37816815
[TBL] [Abstract] [Full Text] [Related]
4. Risk factors for cervical lymph node metastasis in the central or lateral cervical region in medullary thyroid carcinoma: a systematic review and meta-analysis.
Lin X; Huo J; Su H; Zhu C; Xu Y; Zhang F
Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):547-561. PubMed ID: 37801162
[TBL] [Abstract] [Full Text] [Related]
5. Impact of BCL-2 Expression on Course of Disease in Neuroblastoma.
Muehling J; Fröba-Pohl A; Muensterer OJ; von Schweinitz D; Kappler R
Eur J Pediatr Surg; 2024 Feb; 34(1):69-77. PubMed ID: 37774735
[TBL] [Abstract] [Full Text] [Related]
6. Prediagnostic Hormone Levels and Risk of Testicular germ cell tumors: A Nested Case-Control Study in the Janus Serum Bank.
Wu Z; Trabert B; Guillemette C; Caron P; Bradwin G; Graubard BI; Weiderpass E; Ursin G; Langseth H; McGlynn KA
Cancer Epidemiol Biomarkers Prev; 2023 Nov; 32(11):1564-1571. PubMed ID: 37619591
[TBL] [Abstract] [Full Text] [Related]
7. Mycophenolate mofetil reduces the risk of relapse in anti-leucine-rich glioma-inactivated protein 1 encephalitis: a prospective observational cohort study.
Liu M; Xu X; Fan S; Ren H; Zhao Y; Guan H
Neurol Sci; 2024 Jan; 45(1):253-260. PubMed ID: 37580515
[TBL] [Abstract] [Full Text] [Related]
8. Rapamycin and rapalogs for tuberous sclerosis complex.
Sasongko TH; Kademane K; Chai Soon Hou S; Jocelyn TXY; Zabidi-Hussin Z
Cochrane Database Syst Rev; 2023 Jul; 7(7):CD011272. PubMed ID: 37432030
[TBL] [Abstract] [Full Text] [Related]
9. Selection of iPSCs without mtDNA deletion for autologous cell therapy in a patient with Pearson syndrome.
Lee Y; Han J; Hwang SB; Kang SS; Son HB; Jin C; Kim JE; Lee BH; Kang E
BMB Rep; 2023 Aug; 56(8):463-468. PubMed ID: 37156631
[TBL] [Abstract] [Full Text] [Related]
10. Epigenomic and transcriptomic landscaping unraveled candidate repositioned therapeutics for non-functioning pituitary neuroendocrine tumors.
Aydin B; Beklen H; Arga KY; Bayrakli F; Turanli B
J Endocrinol Invest; 2023 Apr; 46(4):727-747. PubMed ID: 36306107
[TBL] [Abstract] [Full Text] [Related]
11. Acid and Alkaline Phosphatases Specific activities and Expression as Biomarkers in Brain tumor Grading and Correlation of Anaplastic Oligodendroglioma G-III to Meningiomas G-I among Brain tumors and their primary culture.
Muddobalaiah P; Ravi V; Thammanna CC; Sagar BKC; Swamy NSR
J Chem Neuroanat; 2022 Nov; 125():102140. PubMed ID: 35914649
[TBL] [Abstract] [Full Text] [Related]
12. Is There a Role for Surgical Resection of Grade 3 Neuroendocrine Neoplasms?
Borbon LC; Tran CG; Sherman SK; Ear PH; Chandrasekharan C; Bellizzi AM; Dillon JS; O'Dorisio TM; Howe JR
Ann Surg Oncol; 2022 Oct; 29(11):6936-6946. PubMed ID: 35802214
[TBL] [Abstract] [Full Text] [Related]
13. Melanoma Molecular Subtypes and Development of Prognostic and Immunotherapy-Related Genetic Characteristics by Ferroptosis Gene Analysis.
Xu L; Zhang Y; Liu T; Wang L; Zhao Z; Zhang X; Li X; Wu W; Yu S
Comput Math Methods Med; 2022; 2022():2992939. PubMed ID: 35516454
[TBL] [Abstract] [Full Text] [Related]
14. Risk of a Second Skin Cancer in a Cohort of Patients With Nonmelanoma Skin Cancer -Basal cell Carcinoma or Squamous cell Carcinoma-Treated With Mohs Micrographic Surgery: A National Prospective Cohort Study.
Miñano Medrano R; López Estebaranz JL; Sanmartin-Jiménez O; Garcés JR; Rodríguez-Prieto MA; Vilarrasa-Rull E; de Eusebio-Murillo E; Escutia-Muñoz B; Flórez-Menéndez Á; Artola-Igarza JL; Alfaro-Rubio A; Redondo P; Delgado-Jiménez Y; Sánchez-Schmidt JM; Allende-Markixana I; Alonso-Pacheco ML; García-Bracamonte B; de la Cueva-Dobao P; Navarro-Tejedor R; Ciudad-Blanco C; Carnero-González L; Vázquez-Veiga H; Cano-Martínez N; Ruiz-Salas V; Sánchez-Sambucety P; Botella-Estrada R; González-Sixto B; Martorell-Calatayud A; Gil P; Morales-Gordillo V; Toll-Abelló A; Ocerin-Guerra I; Mayor-Arenal M; Suárez-Fernández R; Sainz-Gaspar L; Descalzo MA; García-Doval I;
Actas Dermosifiliogr; 2022 May; 113(5):451-458. PubMed ID: 35431059
[TBL] [Abstract] [Full Text] [Related]
15. Detection of disease-causing mutations in prostate cancer by NGS sequencing.
Mangolini A; Rocca C; Bassi C; Ippolito C; Negrini M; Dell'Atti L; Lanza G; Gafà R; Bianchi N; Pinton P; Aguiari G
Cell Biol Int; 2022 Jul; 46(7):1047-1061. PubMed ID: 35347810
[TBL] [Abstract] [Full Text] [Related]
16. Clinicopathologic and Molecular Study of Hybrid Nerve Sheath tumors Reveals Their Common Association With Fusions Involving VGLL3.
Nihous H; Baud J; Azmani R; Michot A; Perret R; Mayeur L; de Pinieux G; Milin S; Angot E; Duquenne S; Geneste D; Lucchesi C; Le Loarer F; Bouvier C
Am J Surg Pathol; 2022 May; 46(5):591-602. PubMed ID: 35256555
[TBL] [Abstract] [Full Text] [Related]
17. Medulloblastoma cerebrospinal fluid reveals metabolites and lipids indicative of hypoxia and cancer-specific RNAs.
Lee B; Mahmud I; Pokhrel R; Murad R; Yuan M; Stapleton S; Bettegowda C; Jallo G; Eberhart CG; Garrett T; Perera RJ
Acta Neuropathol Commun; 2022 Feb; 10(1):25. PubMed ID: 35209946
[TBL] [Abstract] [Full Text] [Related]
18. Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis.
Goldinger SM; Buder-Bakhaya K; Lo SN; Forschner A; McKean M; Zimmer L; Khoo C; Dummer R; Eroglu Z; Buchbinder EI; Ascierto PA; Gutzmer R; Rozeman EA; Hoeller C; Johnson DB; Gesierich A; Kölblinger P; Bennannoune N; Cohen JV; Kähler KC; Wilson MA; Cebon J; Atkinson V; Smith JL; Michielin O; Long GV; Hassel JC; Weide B; Haydu LE; Schadendorf D; McArthur G; Ott PA; Blank C; Robert C; Sullivan R; Hauschild A; Carlino MS; Garbe C; Davies MA; Menzies AM
Eur J Cancer; 2022 Feb; 162():22-33. PubMed ID: 34952480
[TBL] [Abstract] [Full Text] [Related]
19. Risk of Developing Melanoma With Systemic Agents Used to Treat Psoriasis: A Review of the Literature.
Semaka A; Salopek TG
J Cutan Med Surg; 2022; 26(1):87-92. PubMed ID: 34392725
[TBL] [Abstract] [Full Text] [Related]
20. Liquid Biopsy and Radiological Response Predict Outcomes Following Discontinuation of Targeted Therapy in Patients with BRAF Mutated Melanoma.
Di Guardo L; Randon G; Corti F; Vallacchi V; Raimondi A; Fucà G; Bini M; Maurichi A; Patuzzo R; Gallino G; Mattavelli I; Ruggeri R; Angi M; Cossa M; Valeri B; Cimminiello C; Santinami M; Rivoltini L; de Braud F; Rodolfo M; Vecchio MD
Oncologist; 2021 Dec; 26(12):1079-1084. PubMed ID: 34355463
[TBL] [Abstract] [Full Text] [Related]
[Next]